American Association of Critical-Care Nurses (AACN)

Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges

Article in Critical Care Nurse details how Atrium Health’s virtual critical care unit supported bedside colleagues, while reducing exposure time and conserving personal protective equipment.

Newswise — Atrium Health’s tele-ICU is a key element in the North Carolina health system's strategy to address challenges of providing care for patients with COVID-19.

The pandemic has not only highlighted existing nursing shortages but also created unique concerns of its own, as surge planning strains already stretched staffing resources. In addition, the nursing profession grew especially concerned about the health and safety of its workforce, specifically the consistent availability of critical care nurses and sufficient supplies of personal protective equipment (PPE) throughout the pandemic.

Answering the Call: Impact of Tele-ICU Nurses During the COVID-19 Pandemic” describes how Atrium Health’s tele-ICU quickly adjusted its patient-centered focus to include supporting and protecting bedside nurses caring for patients in isolation, as part of the system’s planning and preparations for the pandemic. The article is published in the August issue of Critical Care Nurse (CCN).

The virtual critical care unit (VCC) has been providing tele-ICU care in Atrium Health’s network of hospitals and ICUs across the Carolinas since 2013. The VCC uses real-time, two-way audio and high-definition video communication to hundreds of critical care beds and via mobile carts in two emergency departments in the health system. The VCC team has more than 80 board-certified tele-intensivists and 40 board-certified critical care nurses.

“We modified workflows, deployed home workstations and changed staffing models with the goal of providing additional clinical support to bedside colleagues while reducing exposure time and conserving PPE,” said co-author and VCC program coordinator Sandy Arneson, MSN, RN, CCRN-E. “VCC capabilities facilitate both a high level of care for patients and protection for frontline providers.”

As part of the system’s surge preparations, VCC coverage was quickly expanded to the facilities that were first to admit patients diagnosed with COVID-19. At these facilities, the VCC expansion enabled conversion of existing hospital beds to critical care beds, more than doubling capacity for ICU-level care.

The infrastructure expansion included deploying telemedicine mobile carts throughout the system. Many non-VCC providers were granted access to its tele-ICU software to facilitate team-based care of patients with COVID-19, and handheld tablets were distributed to increase family-centered visitation and virtual communication.

To assure consistent coverage in the event of required quarantine or exposure, a team of VCC nurses, as well as members of the VCC operational and leadership team received home workstations with laptops and additional monitors.

Workflow modifications help reduce time spent in isolation rooms and thereby reduce the risk of exposure for frontline caregivers.

The COVID-19 pandemic had the potential to exacerbate any staffing challenges, and the VCC team provided an additional layer of clinical support to nurses at the bedside. At the push of a button, bedside clinicians had immediate access to experienced ICU nursing support.

This ease of access also gave bedside nurses peace of mind, knowing that changes in a patient’s status would be brought to their attention quickly, even when they were not in the same room. For example, a VCC nurse could perform clinical documentation while the bedside ICU nurse conducted a physical patient assessment, a task which could be challenging in full PPE.

As the American Association of Critical-Care Nurses’ (AACN) bimonthly clinical practice journal for acute and critical care nurses, CCN is a trusted source of information related to the bedside care of critically and acutely ill patients.

The article is part of AACN’s growing library of clinical resources related to caring for critically ill patients with COVID-19, including a free self-paced course, “COVID-19 Pulmonary, ARDS and Ventilator Resources.” The COVID-19 resources also include free pocket cards, webinars, procedure manual excerpts and journal articles.

Access the article abstract and full-text PDF by visiting the CCN website at http://ccn.aacnjournals.org.

About Critical Care Nurse: Critical Care Nurse (CCN), a bimonthly clinical practice journal published by the American Association of Critical-Care Nurses, provides current, relevant and useful information about the bedside care of critically and acutely ill patients. The award-winning journal also offers columns on traditional and emerging issues across the spectrum of critical care, keeping critical care nurses informed on topics that affect their practice in acute, progressive and critical care settings. CCN enjoys a circulation of more than 120,000 and can be accessed at http://ccn.aacnjournals.org/.

About the American Association of Critical-Care Nurses: For more than 50 years, the American Association of Critical-Care Nurses (AACN) has been dedicated to acute and critical care nursing excellence. The organization’s vision is to create a healthcare system driven by the needs of patients and their families in which acute and critical care nurses make their optimal contribution. AACN is the world's largest specialty nursing organization, with more than 120,000 members and over 200 chapters in the United States.

American Association of Critical-Care Nurses, 27071 Aliso Creek Road, Aliso Viejo, CA 92656; 949-362-2000; www.aacn.org; facebook.com/aacnface; twitter.com/aacnme

 

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
Does a New Study Give Evidence that the Coronavirus Was Made In a Lab?
Newswise

Scientists in a new paper make strong claims regarding evidence that the COVID-19 virus did not originate in nature—the prevailing theory—but instead was made in a lab. According to six leading experts in evolutionary biology and infectious disease consulted by Newsweek, the paper offers no new information, makes numerous unsubstantiated claims and its scientific case is weak.


Showing results

110 of 3321

close
1.13857